MarketWatchMarkets1h ago
Lilly’s new GLP-1 pill is off to a ‘robust’ start
Lilly’s new GLP-1 pill had 1,390 prescriptions in its first week on the market.
Press Releases via PressAgent
More Markets
Even OpenAi’s top economist thinks the AI job apocalypse is overstated. Here’s why.
MarketWatch · 59m ago
Think the rally is safe? This elite market-timing indicator says a correction is overdue.
MarketWatch · 1h ago
The world’s most stable asset is losing its grip — leaving your paycheck and retirement vulnerable to inflation
MarketWatch · 2h ago
Signs point to a solid earnings season — and with the S&P 500 topping 7,000, you should believe them
MarketWatch · 2h ago